CAM
WVE icon

Cormorant Asset Management’s Wave Life Sciences WVE Stock Holding History

Cormorant Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-202,079
Closed -$7.09M – 58
2017
Q4 		$7.09M Hold
202,079
– – 0.74% 31
2017
Q3 		$4.39M Hold
202,079
– – 0.78% 36
2017
Q2 		$3.76M Sell
202,079
-280,000
-58% -$6.03M 0.62% 42
2017
Q1 		$13.3M Sell
482,079
-25,828
-5% -$721K 1.93% 19
2016
Q4 		$13.3M Hold
507,907
– – 1.79% 19
2016
Q3 		$16.5M Buy
507,907
+113,500
+29% +$2.68M 1.82% 19
2016
Q2 		$8.16M Buy
394,407
+2,328
+0.6% +$36.3K 1.16% 30
2016
Q1 		$5.44M Hold
392,079
– – 0.82% 40
2015
Q4 		$6.25M Buy
+392,079
New +$6.15M 0.75% 42

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Cormorant Asset Management's WVE Position: Q1 2018 in Review

Cormorant Asset Management sold out of Wave Life Sciences (WVE) in Q1 2018, closing a stake of 202,079 shares — an estimated $7.09M sold.

Cormorant Asset Management first reported a position in WVE in Q4 2015 and held it in 9 quarters. The position peaked at $16.5M in Q3 2016. 79 funds tracked by Wall St. Rank hold WVE as of Q1 2018.

  • Cormorant Asset Management reported no remaining Wave Life Sciences position as of Q1 2018 after selling out during the quarter.
  • Cormorant Asset Management sold 202,079 Wave Life Sciences shares in Q1 2018, an estimated $7.09M.
  • Cormorant Asset Management first reported a position in Wave Life Sciences in Q4 2015 and held it in 9 quarters.
  • Cormorant Asset Management's Wave Life Sciences position peaked at $16.5M in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2018.

Based on Cormorant Asset Management's 13F filing for Q1 2018, filed 15 May 2018.